深圳华润九新药业有限公司
- Country
- Ownership
- -
- Established
- 1992-01-27
- Employees
- -
- Market Cap
- -
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
65
NMPA:65
Drug Approvals
Ceftobiprole Medocaril Sodium for Injection
- Product Name
- 注射用头孢比罗酯钠
- Approval Number
- 国药准字H20253861
- Approval Date
- Apr 8, 2025
NMPA
Ceftizoxime Sodium for Injection
- Product Name
- 注射用头孢唑肟钠
- Approval Number
- 国药准字H20253049
- Approval Date
- Jan 2, 2025
NMPA
Ceftizoxime Sodium for Injection
- Product Name
- 注射用头孢唑肟钠
- Approval Number
- 国药准字H20253050
- Approval Date
- Jan 2, 2025
NMPA
Amoxicillin Sodium and Clavulanate Potassium for Injection（Ⅱ）
- Product Name
- 注射用阿莫西林钠克拉维酸钾(Ⅱ)
- Approval Number
- 国药准字H20234479
- Approval Date
- Dec 29, 2023
NMPA
Amoxicillin Sodium and Clavulanate Potassium for Injection（Ⅱ）
- Product Name
- 注射用阿莫西林钠克拉维酸钾(Ⅱ)
- Approval Number
- 国药准字H20234480
- Approval Date
- Dec 29, 2023
NMPA
Cefuroxime Sodium for Injection
- Product Name
- 凯帝欣
- Approval Number
- 国药准字H20050303
- Approval Date
- Dec 11, 2023
NMPA
Cefuroxime Sodium for Injection
- Product Name
- 凯帝欣
- Approval Number
- 国药准字H20050304
- Approval Date
- Dec 11, 2023
NMPA
Cefuroxime Sodium for Injection
- Product Name
- 凯帝欣
- Approval Number
- 国药准字H20041983
- Approval Date
- Dec 11, 2023
NMPA
Cefazolin Sodium Pentahydrate for Injection
- Product Name
- 新泰林
- Approval Number
- 国药准字H20051245
- Approval Date
- Nov 27, 2023
NMPA
Cefazolin Sodium Pentahydrate for Injection
- Product Name
- 新泰林
- Approval Number
- 国药准字H20060601
- Approval Date
- Nov 27, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
Clinical Trials
No trials found
News
No news found